A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation
NCT ID: NCT02140892
Last Updated: 2014-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2014-07-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Chronic Obstructive Pulmonary Disease (COPD) patients are often hospitalized with an Acute Exacerbation of their medical condition.
Those patients usually get only the standard medical care during the acute phase and don't get respiratory physical therapy treatment.
The study's main aim is to investigate if respiratory physical therapy treatment in addition to standard medical care during the acute phase, can improve the respiratory and medical condition and reduce hospitalization stay.
In order to do so we will compare three groups of COPD patients during acute exacerbation; two groups will get one out of two respiratory physical therapy techniques; manually or Intrapulmonary Percussive Ventilator (IPV) in addition to standard medical care and the third group will get standard medical care alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT02329873
Physiotherapy in Exacerbation Chronic Obstructive Pulmonary Disease
NCT01826682
Inspiratory Muscle Training Combined With General Exercise Training in COPD
NCT02392715
Short-course Out-patient Pulmonary Rehabilitation and COPD Exacerbations
NCT02471235
Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD
NCT07020182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
respiratory physical therapy manual technique
respiratory physical therapy manual technique- Autogenic Drainage
respiratory physical therapy manual technique- Autogenic Drainage
respiratory physical therapy technique- IPV
respiratory physical therapy technique- Intrapulmonary Percussive Ventilation
respiratory physical therapy technique- IPV
standart medical care
standard medical care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
respiratory physical therapy manual technique- Autogenic Drainage
respiratory physical therapy technique- IPV
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Respiratory Rate\>25
* PaCO2\> 45 mmHg
* 7.35 \< PH \< 7.38
Exclusion Criteria
* apnea
* glasgow coma scale \< 8
* pneumothorax
* FEV1 \< 50% predicted
* Ischemic Hearth Disease
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-13-0697-YO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.